Date: November 26 – 28, 2018
Venue: US Pharmacopeia, Rockville, MD
Join PharmaLex representatives at the IABS 5th Statistics Workshop-Approaches for CMC Development and Lifecycle Management of Biotherapeutics and Vaccines. Co-organized by the International Alliance for Biological Standardization (IABS) and the FDA this conference e will bring together regulators, and scientists, or those interested in statistics from academia and industry, who have a background in statistics, to help resolve existing challenges in ensuring the quality of biotechnology medicinal products and to bring high quality medicines to patients. Guidance on how to use statistics for a variety of activities required during biotechnology product development such as method development, improvement and replacement, product comparability, biosimilarity exercises and stability program development will be provided by the speakers and panel members.
Bruno Boulanger, Chief Scientific Officer at PharmaLex Statistical Solutions will be delivering a presentation on Bayesian Statistics and Applications on Monday November 26 and Perceval Sondag, Senior Manager, Statistics, PharmaLex US will be chairing a session on Tuesday, November 27 on Examples and Challenges in Biotech and Vaccines Development.
For more information or to register please visit https://iabs.org/index.php/conferences/upcoming-conferences/118-5th-statistical-approaches-for-cmc-development-and-lifecycle-management-of-biotherapeutics-and-vaccines